See also this year's filing and all EDGAR filings for this company.
PDF Report 0000874015_2017_Ionis_Pharmaceuticals_INC.pdf
Logs
| warning | Large missing amount for aggregate "Liabilities" added to remainder. | industry.us_generic | {'missing_ratio': 1.6032273663243315, 'aggregate_val': 812902000, 'exp_sum': 312267000, 'exp_to_value': {'LiabilitiesCurrent': 133784000, 'LiabilitiesNoncurrent': 0, 'remainder_Liabilities': 178483000}} |
Graph
Absolute values for 0000874015, Ionis Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 797,932,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 92,845,000 |
| 3 | remainder_Assets | 21,690,000 |
| 4 | LiabilitiesCurrent | 133,784,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 679,118,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 68,692,157 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 401,717,237 |
| 11 | remainder_Revenues | 394,664,214 |
| 12 | remainder_NetIncome | 19,761,028 |
| 13 | remainder_ComprehensiveNetIncome | -36,315,720 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 912,467,000 |
| 1 | Liabilities | 812,902,000 |
| 2 | Expenses | 470,409,394 |
| 3 | Revenues | 394,664,214 |
| 4 | StockholdersEquity | 99,565,000 |
| 5 | NetIncome | -55,984,152 |
| 6 | ComprehensiveNetIncome | -74,142,012 |
| 7 | BaseVar | 1,323,259,678 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.166 |
| 9 | EconomicCapitalRatio | 1.57 |